N A Halpern

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Can the costs of critical care be controlled?
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA
    Curr Opin Crit Care 15:591-6. 2009
  2. ncbi Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients
    Stephen M Pastores
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Crit Care 11:R48. 2007
  3. ncbi Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, New York, New York, USA
    J Palliat Med 14:483-9. 2011
  4. ncbi Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
    Crit Care Med 38:65-71. 2010
  5. ncbi Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs
    Neil A Halpern
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Care Med 32:1254-9. 2004
  6. ncbi Challenging family dialogues within the intensive care unit: an intensivist's perspective
    Neil A Halpern
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Hosp Med 3:354-6. 2008
  7. ncbi A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 36:721-4. 2005
  8. ncbi Acquisition strategies for critical care technology
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Crit Care Clin 16:545-56. 2000
  9. ncbi Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue M-210, New York, NY 10021, USA
    Bone Marrow Transplant 30:131-4. 2002
  10. ncbi Prevalence and mortality of acute lung injury and ARDS after lung resection
    Alina Dulu
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave M-210, New York, NY 10021, USA
    Chest 130:73-8. 2006

Collaborators

Detail Information

Publications16

  1. ncbi Can the costs of critical care be controlled?
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA
    Curr Opin Crit Care 15:591-6. 2009
    ..By 2005, CCM costs in the US were estimated to be $81.7 billion accounting for 13.4% of hospital costs, 4.1% of the national health expenditures and 0.66% of the gross domestic product...
  2. ncbi Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients
    Stephen M Pastores
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Crit Care 11:R48. 2007
    ..The purposes of this study were to compare the premortem clinical and postmortem diagnoses of cancer patients who died in the ICU and to analyze any discrepancies between them...
  3. ncbi Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, New York, New York, USA
    J Palliat Med 14:483-9. 2011
    ..Our objective was to provide a contemporary analysis of the prevalence, types, and impact of advance health care directives in critically ill cancer patients...
  4. ncbi Critical care medicine in the United States 2000-2005: an analysis of bed numbers, occupancy rates, payer mix, and costs
    Neil A Halpern
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
    Crit Care Med 38:65-71. 2010
    ..To analyze the evolving role, patterns of use, and costs of critical care medicine in the United States from 2000 to 2005...
  5. ncbi Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs
    Neil A Halpern
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Care Med 32:1254-9. 2004
    ..To establish a database that permits description and analysis of the evolving role, patterns of use, and costs of critical care medicine (CCM) in the United States from 1985 to 2000...
  6. ncbi Challenging family dialogues within the intensive care unit: an intensivist's perspective
    Neil A Halpern
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Hosp Med 3:354-6. 2008
  7. ncbi A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 36:721-4. 2005
    ..The small number of patients in this report precludes a definitive assessment of the safety and efficacy of Drot AA in HSCT patients...
  8. ncbi Acquisition strategies for critical care technology
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Crit Care Clin 16:545-56. 2000
    ..Ultimately, it is hoped that technological breakthroughs coupled with a standardized approach to delivery of ICU services in the coming decades will ensure better and more efficient care to critically ill patients...
  9. ncbi Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C
    S M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue M-210, New York, NY 10021, USA
    Bone Marrow Transplant 30:131-4. 2002
    ..This case illustrates the potential application of a novel therapeutic approach. Clinical trials are warranted to further investigate the safety and efficacy of drotrecogin alfa (activated) in patients with severe sepsis after HSCT...
  10. ncbi Prevalence and mortality of acute lung injury and ARDS after lung resection
    Alina Dulu
    Critical Care Medicine Service, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave M-210, New York, NY 10021, USA
    Chest 130:73-8. 2006
    ..06). CONCLUSIONS: Our results confirm that ALI/ARDS after lung resection is associated with a high mortality in patients who require invasive MV and ICU care...
  11. ncbi Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two United States federal Medicare databases
    Neil A Halpern
    Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Crit Care Med 35:692-9. 2007
    ..A comparison of federal Medicare databases to identify critical care medicine (CCM) use, cost discrepancies, and their possible causes...
  12. ncbi Management dilemmas due to a paratracheal follicular dendritic cell tumor
    Louis P Voigt
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 82:1898-900. 2006
    ..This malignant tumor created numerous management dilemmas and therapeutic challenges related to the unstable airway and the need for tracheal stenting to bypass the airway obstruction...
  13. ncbi Changes in critical care beds and occupancy in the United States 1985-2000: Differences attributable to hospital size
    Neil A Halpern
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Crit Care Med 34:2105-12. 2006
    ..In addition, CCM bed occupancy is greater in larger institutions. These findings may help guide the future development of hospital size-based CCM benchmarking standards and guidelines...
  14. ncbi Implementing an electronic medical record
    Lloyd N Friedman
    Pulmonary and Critical Care Section, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    Crit Care Clin 23:347-81. 2007
    ..The reader will gain a full understanding of the scope of the problems involved in implementing an EMR, and will have a step-by-step description of how to approach the task...
  15. ncbi Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy
    David J Bentrem
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 9:1307-12. 2005
    ..4). The majority of patients who undergo PD do not require admission to the ICU. Factors most associated with ICU admission after PD are increased preoperative BMI and intraoperative blood loss...
  16. ncbi Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa
    Stephen M Pastores
    Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue M-210, New York, NY 10021, USA
    Chest 124:2400-3. 2003
    ..We report a case of DAH after allogeneic HSCT that failed standard therapy and was then successfully treated with rFVIIa...